PHARMASCHMIDT
ActivePHARMASCHMIDT has been active since 2010 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €256k and a net result of €69k. Equity is growing by ~18.4% per year across the filed fiscal years. Its solvency ranks better than 53% of 4602 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2024
79
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability86▲+3
Solvency77▲+15
Growth78=
Track record100
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €20k at 30 days acceptable
Liquidity ample (current ratio 1.75 against 1.45 in 2023; short-term debt: 34.9% and cash: 15.4% of total assets), and 47.8% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 70
Relative position
BE, all sectors
reference
Sector 70
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 15-09-2025, 46 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
46 d late
2023
35 d early
2022
38 d late
2021
31 d late
2020
31 d late
2019
60 d late
← before the deadline
after the deadline →
Financials · fiscal year 2024, full schema
Turnover
€0
2023 · €0
2018: €0
2019: €0
2020: €0
2021: €0
2022: €0
2023: €0
2018 → 2024
EBIT margin
Not included in this filing
Net result
€69k▲ 14.9%
2023 · €60k
2018: €2k
2019: €13k
2020: €31k
2021: €36k
2022: €59k
2023: €60k
2018 → 2024
Working capital
€128k▲ 26.4%
2023 · €101k
2018: €68k
2019: €80k
2020: €83k
2021: €113k
2022: €156k
2023: €101k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Turnover€0-€0€0€0€0
Equity€111k-€147k▲ 32.7%€202k▲ 37.4%€200k▼ 1.3%€256k▲ 28.0%
Operating result€67k-€74k▲ 9.6%€105k▲ 41.9%€103k▼ 1.9%€103k▲ 0.3%
Net result€31k-€36k▲ 17.6%€59k▲ 63.3%€60k▲ 0.7%€69k▲ 14.9%
Result per fiscal year
Operating resultNet result
The operating result recovers in 2024; 2024 is 0% above 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €490k
Fixed assets
€192k▼ 8.3%
Current assets
€299k▼ 8.5%
Equity and liabilities €490k
Equity
€256k▲ 28.0%
Debt
€235k▼ 30.1%
The debt ratio falls from 62.7% to 47.8%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€139k▼
2023 · €169k
Cash flow
€104k▼
2023 · €126k
Solvency
52.2%▲
2023 · 37.3%
Current ratio
1.75▲
2023 · 1.45
Quick ratio
1.08▲
2023 · 0.99
Debt / equity
0.92▼
2023 · 1.68
ROE
26.8%▼
2023 · 29.9%
ROA
14.0%▲
2023 · 11.2%
Interest coverage
19.27▲
2023 · 18.30
Debt
€235k▼
2023 · €336k
Debt ≤ 1 year
€171k▼
2023 · €225k
Debt > 1 year
€64k▼
2023 · €110k
Income taxes
€28k▼
2023 · €34k
Staff costs
€96k▲
2023 · €68k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet
Code20232024
Assets
Total assets20/58€535k€490k▼
Fixed assets21/28€209k€192k▼
Intangible fixed assets21€0€0=
Tangible fixed assets22/27€208k€191k▼
Land and buildings22€200k€183k▼
Plant, machinery and equipment23€3k€3k▼
Furniture and vehicles24€5k€5k▲
Other tangible fixed assets26€0€0=
Assets under construction and advance payments27-€0
Financial fixed assets28€1k€1k=
Current assets29/58€326k€299k▼
Stocks and contracts in progress3€104k€114k▲
Stocks30/36€104k€114k▲
Amounts receivable within one year40/41€80k€103k▲
Trade receivables40€80k€90k▲
Other amounts receivable41€0€12k▲
Cash at bank and in hand54/58€138k€76k▼
Deferred charges and accrued income490/1€5k€6k▲
Equity and liabilities
Total equity and liabilities10/49€535k€490k▼
Equity10/15€200k€256k▲
Contributions10/11€1k€1k=
Reserves13€199k€255k▲
Non-distributable reserves130/1€0-
Reserves not available under the articles1311€0-
Distributable reserves133€199k€255k▲
Profit (loss) carried forward14€0-
Amounts payable17/49€336k€235k▼
Amounts payable after more than one year17€110k€64k▼
Financial debts170/4€110k€64k▼
Amounts payable within one year42/48€225k€171k▼
Current portion of amounts payable after more than one year42€71k€47k▼
Financial debts43€0-
Credit institutions430/8€0-
Trade debts44€79k€97k▲
Suppliers440/4€79k€97k▲
Taxes, remuneration and social security45€36k€14k▼
Taxes450/3€29k€5k▼
Remuneration and social security454/9€7k€9k▲
Other amounts payable47/48€39k€12k▼
Income statement
Code20232024
Turnover70€0€0=
Goods, raw materials, services and sundry goods60/61€0€0=
Remuneration, social security and pensions62€68k€96k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€66k€36k▼
Other operating charges640/8€2k€2k▲
Non-recurring operating charges66A€378€64▼
Gross operating margin9900€240k€237k▼
Operating profit (loss)9901€103k€103k▲
Financial income75/76B€215€311▲
Recurring financial income75€215€311▲
Financial charges65/66B€9k€7k▼
Recurring financial charges65€9k€7k▼
Profit (loss) for the period before taxes9903€94k€96k▲
Income taxes67/77€34k€28k▼
Profit (loss) for the period9904€60k€69k▲
Profit (loss) for the period to be appropriated9905€60k€69k▲
Appropriation of the result
Profit (loss) to be appropriated9906€100k€69k▼
Profit (loss) brought forward from the previous period14P€41k-
Transfer from equity791/2€4k€13k▲
Transfer to equity691/2€60k€69k▲
To the legal reserve6920€0-
To other reserves6921€60k€69k▲
Profit to be distributed694/7€45k€13k▼
Return on contributions (dividend)694€45k€13k▼
Social balance
Average headcount (FTE)90871.41.7▲
The notes to these accounts (15 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
15-09
NBB filing
Annual accounts filed
fiscal year 2024 · full schema · 46 days late
2024
31-12
Financial
Highest result since 2018net €69k ▲14.9%
Net result €69k, the highest in the series.
31-12
Financial
Equity above €200kEq €256k ▲28%
7 profitable years in a row build equity to €256k.
26-06
NBB filing
Annual accounts filed
fiscal year 2023 · full schema
2023
07-09
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 38 days late
2022
31-12
Financial
Equity above €200kEq €202k ▲37.4%
5 profitable years in a row build equity to €202k.
31-08
NBB filing
Annual accounts filed
fiscal year 2021 · full schema · 31 days late
2021
31-08
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 31 days late
2020
29-09
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 60 days late
2019
31-12
Financial
Equity above €100kEq €105k ▲12.6%
2 profitable years in a row build equity to €105k.
23-08
NBB filing
Annual accounts filed
fiscal year 2018 · full schema · 23 days late
2018
30-08
NBB filing
Annual accounts filed
fiscal year 2017 · full schema · 30 days late
2017
29-08
NBB filing
Annual accounts filed
fiscal year 2016 · full schema · 29 days late
2016
26-07
NBB filing
Annual accounts filed
fiscal year 2015 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
5 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Liège · 1 establishment unit since 2010
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Rue Hippolyte-Cornet 44032 LiègeGround area
111 m²
Building footprint
54 m²
Volume, LiDAR
626 m³
Parcel 62023A0774/00F000, Wallonia · tallest building 13.4 m, ±4 floors. Linked by address, not a title deed.
1 establishment unit
PHARMASCHMIDT
since 20102.187.993.267
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 62023A0774/00F000 | Wallonia | 111 m² | 1 · 54 m² | 13.4 m · 4 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Food safety, FASFC
1 siteLiège2.187.993.267
Similar companies · same sector, comparable size
JMS FINANCE
BE 0505.821.940
Gembloux · Eq €256k
Kick It Off
BE 0739.727.443
Chastre · Eq €256k
nexyan
BE 0874.788.560
Brussel · Eq €256k
Margo Tijaan
BE 0698.662.393
Rumst · Eq €256k
SELOFRA
BE 0729.582.827
Ottignies-Louvain-la-Neuve · Eq €256k
Of 82,569 companies in sector 70200 we hold annual accounts for 52,577. 38,845 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded30-03-2010
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
70200Business and other management consultancy
70220Business consulting
Sources
Crossroads Bank for EnterprisesNational Bank · 15 filingsAddress and cadastre registers
Data from official sources, last processed on 22-09-2026. Scores and ratios are computed by Checked and are not a credit decision.